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Currently embryonic stem cells (ESCs) derived from ferti-
lized embryos or cloned embryos by somatic cell nuclear 
transfer and induced pluripotent stem cells (iPSCs) from 
somatic cells represent two major types of pluripotent stem 
cells (PSCs). The naïve PSCs functionally can produce all 
ESC/iPSC mice by tetraploid embryo complementation, and 
contribute to blastocyst chimeras with germline competency, 
while primed state PSCs including epiblast stem cells 
(EpiSCs) are not competent to contribute to blastocyst chi-
meras, and yet most human PSCs arguably are analogous to 
rodent EpiSCs. Nonetheless, derivation of germ cells from 
PSCs would be of significance in both basic research in 
germ cell biology and potential clinic applications. For in-
stance, in vitro recapitulation of gametogenesis by induced 
germ cells expectedly can facilitate our further understand-
ing at the molecular and single cell levels in dynamics of 
germ cell specification, meiosis and gametogenesis. These 
materials are not readily accessible particularly in humans. 
Moreover, infinite supply of germ cells from autologous 
pluripotent stem cells may be used for fertility treatment 
and other forms of assisted reproductive technology (ART) 
including mitochondria replacement therapy and somatic 
cell nuclear transfer. 
Derivation of primordial germ cells (PGCs) is the first 
step toward realization of gametogenesis from PSCs. Excit-
ingly, generation of PGCs-like cells (or PGCLCs) and func-
tional gametes (sperm or eggs) that produced live offspring 
from mouse ESCs/iPSCs have been successfully achieved 
in mice by Saitou lab using a combined in vitro and in vivo 
induction system [1,2] (Figure 1), although the efficiency is 
still low, and long-term safety needs to be addressed. By a 
two-step differentiation method, female ESCs and iPSCs 
were induced to epiblast-like cells (EpiLCs) using Activin 
A and basic fibroblast growth factor (FGF), the same cyto-
kines for culture of EpiSCs. After 2 days of differentiation, 
EpiLCs in the presence of BMP4 gave rise to PGCLCs. 
Thus, ESCs transit to a primed epiblast-like state first as in 
vivo, and then gain the competence to form PGCs in vitro. 
Reconstituted ovaries were generated by re-aggregation of 
PGCLCs with E12.5 gonadal somatic cells, followed by 
transplantation of the reconstituted ovaries under ovarian 
bursa, such that the PGCLCs in the reconstituted aggregates 
underwent X-reactivation, imprint erasure, meiosis progres-
sion and oocyte growth. After isolating a donor ovarian por-
tion, fully-grown GV oocytes were collected and underwent 
in vitro maturation to generate functional oocytes. However, 
the conditions to efficiently derive authentic PGCs resem-
bling in vivo counterparts directly from ESCs in vitro re-
main to be optimized. In future, complete in vitro induction 
system without use of gonadal tissues needs to be explored 
for the differentiation of female ESCs and iPSCs into germ 
cells and recapitulation of gametogenesis in vivo. 
Significant progress has also been made in the differenti-
ation to germ cells from human ESCs/iPSCs over the last 
decade [35]. Notably, Kee et al. [6] were able to isolate 
PGCs from the complex cell mixture derived from both 
male and female human ESCs using a green fluorescent 
protein (GFP)-VASA reporter. Moreover, overexpression of 
DAZL, DAZ and BOULE induces meiotic progression and 
haploid formation [6]. Human iPSCs can be differentiated  
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into the male germline, including haploid, round spermatid- 
like cells [4,5]. In contrast, differentiation of iPSCs/ESCs 
into female germ cells has been low in efficiency. Eguizabal 
et al. consistently observed between 1.0%–2.0% haploid 
cells from each human female iPSC line in the two-step 
differentiation protocol [5]. 
In mice, during early gastrulation (E5.0–E6.5), the 
proximal epiblasts directly contact with the signaling from 
the extra-embryonic ectoderm (ExE) and acquire compe-
tence to respond to BMP4-Prdm1/Prdm14, determining 
germ cell fates specified to PGCs. In humans, however, an 
equivalent structure to the murine ExE does not exist and 
the PGCs initiate by the end of the third week of gestation. 
These differences may suggest the existence of different 
mechanisms for PGC specification, in association with the 
divergent success in germ cell derivation from PSCs in 
mouse or human origin.  
Indeed, SOX17 recently has been discovered to play a 
critical role in generation of hPGCLCs from human ESCs/ 
iPSCs [7]. The new study employed a PGC-specific 
NANOS3-mCherry knockin reporter and efficiently (27%) 
induced hPGCLCs in the presence of BMP2 or BMP4, LIF, 
stem cell factor (SCF), epidermal growth factor (EGF) [1], 
and Rho-kinase (ROCK) inhibitor, from hESC-NANOS3- 
mCherry cells that were maintained in four-inhibitor- con-
taining medium with LIF, bFGF, and TGFb (called ‘‘4i’’ 
medium, which endows the cells with a distinct ‘naïve’ plu-
ripotent state). Moreover, by RNA-seq analysis of 
hPGCLCs in comparison with fetal hPGCs and by analysis 
of sequential gene expression during hPGCLC specification 
in embryoids as well as knockout experiments, SOX17- 
BLIMP1 are found to be the critical determinant of hPGC 
specification and maintenance. SOX17 is the key regulator 
of hPGCLC specification, which acts upstream of BLIMP1 
(PRDM1), whereas BLIMP1 represses endodermal and 
other somatic genes during hPGCLC specification (Figure 
1). Additionally, CD38/TNAP are found to be reliable 
markers for the isolation of hPGCLCs derived from 
hESCs/hiPSCs without any reporters. 
Hence, use of naïve human PSCs can be critical for effi-
cient generation of PGCLCs in vitro. Furthermore, 
PRDM14 may not be important for human PGC specifica-
tion, unlike mice. The next question is how SOX17 expres-
sion is regulated during induced differentiation of PGCLCs 
from human PSCs in response to BMP signaling. 
Intriguingly, by Hayashi et al. [1], PGCLCs were gener-
ated from ESCs and iPSCs through EpiLCs, a state highly 
similar to epiblasts but distinct from EpiSCs. In addition, 
Integrin-3 and SSEA1 were identified as markers for iso-
lating PGCLCs from differentiated cells. Human 
ESCs/iPSCs are more similar to mouse EpiSCs derived 
from postimplantation epiblasts than mouse naive ESCs. 
Whether the PGCLCs derived from naïve human 
ESCs/iPSCs in the new study [7] also passed by EpiLCs at 
an intermediate stage is not reported. Also, this Cell study 
reiterates that PSCs provide powerful sources for deeper 
understanding of molecular mechanisms underlying lineage 
specifications in vitro that is arduous to achieve using in 
vivo materials, e.g., PGC specification in this case. 
PGC specification is only the first step in creating human 
sperm and ova. It is a long way to go and remains to be de-
termined whether these PGCs differentiated from human 
ESCs/iPSCs are able to undergo normal meiosis in vitro or 
in vivo and generate functional sperm or eggs. However, the 
findings in this new study should lay good foundation for 
further study in mechanism of PGC determination in hu-
mans and in generation of functional gametes (sperm or 
oocytes) for fertility treatment eventually.  
There are still too many unknowns to introduce the arti-
ficial PGCs into humans and ethic concerns do exist if clinic  
 
 
Figure 1  Generation of germ cells and gametes from pluripotent stem cells in mice and humans. Human naïve ESCs/iPSCs converted and maintained in 
medium supplemented with four inhibitors (‘4i’) are efficiently induced by BMP4 or BMP2 signaling to form hPGCLCs that resemble in vivo PGCs. 
PRDM1, BLIMP1; 4i, CHIR99021, PD0325901, SB203580, and SP600125. SOX17 appears to play a key role in PGC specification from naïve human PSCs, 
whereas Prdm1 and Prdm14 are critical for germ cell specification in mice. 
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tests are planned. PGCLCs derived from naïve human PSCs 
are very similar to fetal PGCs in vivo but differences are 
noticed at the global gene expression profile levels and this 
may be partly caused by stages of PGCs in fetal develop-
ment. Collection of PGCs from earlier fetus may minimize 
the differences. Naïve human PSCs have been generated or 
converted using different protocols. It remains to be ad-
dressed whether naïve human PSCs generated from differ-
ent laboratories using different methods show different effi-
ciency and variations in authentic PGCLSs that mostly re-
semble PGCs in vivo. The next important experiments are to 
instruct the PGCs/PGCLCs undergoing meiosis normally. 
For formation of eggs/oocytes, additional challenges are 
how to coordinate intact folliculogenesis from PGCs/ 
PGCLCs and have oocytes grow and mature normally in 
vitro. In addition, human gametogenesis proceeds on a 
long-term basis with gender differences in meiotic progres-
sion. The differences in signaling mouse and human naïve 
stem cells, and differences in signaling for PGC specifica-
tions suggest that the data obtained from mice may not ex-
actly or wholly extrapolate to humans. Perhaps models us-
ing large animals or non-human primates that mimic human 
germ cell specification and gamete development can be ex-
plored to this direction.  
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